Overview Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma Status: Completed Trial end date: 2006-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of superficial basal cell carcinoma. Phase: Phase 2 Details Lead Sponsor: Peplin